Immunovant (IMVT) shares outstanding

Shares outstanding · fiscal 2026
182.42M

Immunovant (IMVT) had 182.42M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 20.4% higher than the 151.57M of fiscal 2025. Figures as of 18 Nov 2026, 10:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2026
182.42M
Change on fiscal 2025
+20.4%
Growth, 5 years
+15.8% a year
Highest on record
182.42Mfiscal 2026
Lowest on record
87.76Mfiscal 2021
Fiscal years on record
62021–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Immunovant shares outstanding, in more detail

The market data feed counts 206.95M shares outstanding today.

Over the five fiscal years to 2026 the diluted share count grew at a compound 15.8% a year. Across the 6 fiscal years on record (2021–2026), the highest was 182.42M in fiscal 2026 and the lowest 87.76M in fiscal 2021.

History · 6 fiscal years

Shares outstanding by fiscal year

Immunovant shares outstanding, year by year

Immunovant (IMVT) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2026182.42M 20.4% up
2025151.57M 9.8% up
2024138.10M 12.2% up
2023123.08M 12.2% up
2022109.68M 25.0% up
202187.76M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on IMVT

Immunovant, figure by figure

Immunovant (IMVT) overview: price, valuation and scorecardAll health care companies by market value

Immunovant shares outstanding: questions and answers

How many shares does Immunovant have?

Immunovant (IMVT) had 182.42M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 20.4% higher than the 151.57M of fiscal 2025. The market data feed counts 206.95M shares outstanding today.

What is the growth rate of Immunovant's diluted share count?

Over the five fiscal years to 2026 the diluted share count grew at a compound 15.8% a year.

What are the highest and lowest diluted share count figures on record for Immunovant?

Across the 6 fiscal years on record (2021–2026), the highest was 182.42M in fiscal 2026 and the lowest 87.76M in fiscal 2021.

How is Immunovant's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Immunovant it is on record here for 6 fiscal years, 2021 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Immunovant (IMVT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/IMVT/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.